Physician profile
Jacky Chen
NPI 1104491265
$1,285.49
in general payments reported to CMS, 2019-2025
18 companies · $156 in 2025
The $156 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $377 · 2023: $583 · 2024: $169 · 2025: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $908.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $908.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $243.04 | 2022-2025 | Farapulse, Watchman Access System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $185.04 | 2024-2025 | Lifevest |
| Pfizer INC. | $184.51 | 2022-2023 | |
| Novartis Pharmaceuticals Corporation | $139.42 | 2023 | |
| Actelion Pharmaceuticals US, INC. | $127.00 | 2022-2023 | Uptravi, Opsumit |
| Janssen Pharmaceuticals, INC | $71.37 | 2023 | Xarelto |
| Baxter Healthcare | $54.54 | 2022-2023 | Coseal |
| Cvrx, INC. | $44.37 | 2023 | Barostim Neo System |
| Medtronic, INC. | $40.69 | 2025 | Corevalve Evolut R |
| Philips North America LLC | $33.43 | 2022-2023 | |
| Idorsia Pharmaceuticals US INC | $28.95 | 2023 | Quviviq |
| Impulse Dynamics (USA) INC. | $26.72 | 2025 | Optimizer |
| Merck Sharp & Dohme LLC | $22.36 | 2023 | Verquvo |
| Mallinckrodt Hospital Products INC. | $20.72 | 2022 | |
| Jazz Pharmaceuticals INC. | $18.84 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $16.90 | 2023 | Camzyos |
| Astrazeneca Pharmaceuticals Lp | $13.89 | 2022 | |
| Abbott Laboratories | $13.70 | 2025 | Cardiomems |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacky Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.